T
Thomas Martin
Researcher at University of California, San Francisco
Publications - 311
Citations - 17918
Thomas Martin is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Exocytosis. The author has an hindex of 73, co-authored 242 publications receiving 15771 citations. Previous affiliations of Thomas Martin include Institut national de la recherche agronomique & University of Western Australia.
Papers
More filters
Journal ArticleDOI
Bortezomib: Safety and Efficacy in the Treatment of Multiple Myeloma
Thomas Martin,Jeffrey L. Wolf +1 more
TL;DR: This review will discuss the pre-clinical studies evaluating the mechanism of action of proteasome inhibition, outline the clinical development of bortezomib as treatment for patients with newly diagnosed and relapsed multiple myeloma and describe the safety of bortsomib in human studies.
Journal ArticleDOI
P-251: Comparative effectiveness of teclistamab versus real-world physician’s choice of therapy for patients with triple-class exposed relapsed/refractory multiple myeloma
Amrita Krishnan,Ajay K. Nooka,Ajai Chari,Alfred L. Garfall,Thomas Martin,Sandhya Nair,Xiwu Lin,Keqin Qi,Anil Londhe,Lixia Pei,Eric A. Ammann,Rachel Kobos,Jennifer Smit,Trilok V. Parekh,A. Marshall,Mary Slavcev,Saad Z. Usmani +16 more
Journal ArticleDOI
Glycogen synthase kinase 3β localizes to the Z-disc to maintain length dependent activation
Marisa J. Stachowski,Maria Papadaki,Thomas Martin,Weikang Ma,Henry Gong,Stephanie Shao,Shi Shen,Nitha Aima Muntu,Jody L. Martin,Christine S. Moravec,Stuart G. Campbell,Thomas C. Irving,Jonathan A. Kirk +12 more
TL;DR: In this paper , the authors investigated the role, mechanism, and translational relevance of GSK-3β in vivo using inducible cardiomyocyte-specific mice.
Journal ArticleDOI
P898: comparison of teclistamab with belantamab mafodotin in patients with triple-class exposed relapsed/refractory multiple myeloma using matching-adjusted indirect treatment comparison
Margaux Delforge,S. Usmani,N. W. van de Donk,Alfred L. Garfall,Philippe Moreau,Albert Oriol,A. Nooka,Laura Rosiñol,N. Bahlis,Paula Rodriguez-Otero,Thomas Martin,Joris Diels,Suzy Van Sanden,Lixia Pei,Eric A. Ammann,Rachel Kobos,Mary Slavcev,Jennifer Smit,Archana Londhe,Amrita Krishnan +19 more
TL;DR: Book Citations: Authors, Title, HemaSphere, 2022;6:(S3):pages can be found at https://journals.lww.com/hemasphere/pages/default.aspx.
Journal ArticleDOI
Sarcomere remodeling of left atrial myocytes in non-failing atrial fibrillation patients.
Christine E. Delligatti,Parth Desai,Michaela Door,Geena E. Fritzmann,Thomas Martin,Marisa J. Stachowski,Maria Papadaki,David Y. Barefield,Jonathan A. Kirk +8 more
TL;DR: In this paper , the role of the sarcomere in atrial fibrillation has been investigated and the authors identify novel pathways to target therapeutically, using mass spectrometry on left atrial (LA) tissue from patients in Sinus Rhythm (SR, n = 3) or with AF (n = 3).